Facebook
Twitter
LinkedIn
ForwardWebcast - 2021 Updates in Hematologic Malignancies
This accredited continuing education activity “Webcast - 2021 Updates in Hematologic Malignancies”, is recorded from the live oncology conference held on 10/02/2021 at the Hilton Salt Lake City Center in Salt Lake City.
If you participated in the live oncology conference titled - 2021 Updates in Hematologic Malignancies on 10/02/2021 in Salt Lake City and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that conference on 10/02/2021. However, you may enroll in this activity to review the contents.
REGISTRATION FEES:
This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0.
Healthcare providers ($0.00)
Industry employees ($200 + 3% Credit card fee)
If you are a healthcare provider involved in patient care and you are not employed by the Industry, then you don't pay anything to register for this activity.
If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.
If you paid to join the live meeting associated with this webcast and wish to register for this enduring material please contact us and we will register you for free.
Target Audience
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review pertinent clinical trial data for the standard of care and novel management strategies for various hematologic malignancies.
- Integrate and optimally sequence evidence-based treatment plans for various hematologic malignancies based on patient and tumor factors.
- Discuss the mechanism of action, efficacy, indications, and safety of novel targeted therapies and cellular therapies for the management of hematologic malignancies.
- Review current controversies in the management of various hematologic malignancies.
- List appropriate clinical trials for hematologic malignancies
This educational activity features recorded videos from the live conference titled - 2021 Updates in Hematologic Malignancies held on 10/2/2021 at the Hilton Salt Lake City Center in Utah.
The videos are placed in the following order. Feel free to view the content that is relevant to you.
Participants should claim continuing education credits to the extent of their participation.
Session 1: Lymphomas
Moderator: Lindsay Fitzgerald, MD
25 minutes Hodgkin lymphoma – Harsh Shah, DO
25 minutes Aggressive lymphomas – Ryan Lynch, MD
25 minutes Chronic lymphocytic leukemia – Deborah Stephens, DO
27 minutes CAR-T cell therapy for the treatment of Lymphoma – Catherine Lee, MD
Session 2: Leukemias
Moderator: Ashley Newland, PharmD
27 minutes: Acute Myeloid Leukemia – Krishna Gundabolu, MD
26 minutes: Acute lymphoblastic leukemia – Tibor Kovacsovics, MD
16 minutes: Case-based discussion - Charlotte Wagner, PharmD
Session 3: Multiple Myeloma
Moderator: Douglas Sborov, MD
25 minutes: Front line therapy for newly diagnosed multiple myeloma – Ghulam Mohyuddin, MD
24 minutes: Treatment of relapse/refractory multiple myeloma - Shaji Kumar, MD
13 minutes: Case-based discussion - Aman Godara, MD
5 minutes: Case-based discussion - Mary Steinbach, APRN
Session 4: Myeloproliferative Neoplasms
Moderators: Tashi Tsewang, MD
30 minutes: Myeloproliferative neoplasms – Srinivas Tantravahi, MD
25 minutes: Treatment free remission in chronic myeloid leukemia – Jerry Radich, MD
10 minutes: Case-based discussion - Laura Bickel, APRN
 | SRINIVAS TANTRAVAHI, MDAssistant Professor of Medicine University of Utah |  | JERALD RADICH, MDProfessor of Medicine University of Washington, SCCA, Fred Hutch |
 | AMANDEEP GODARA, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |  | TSEWANG TASHI, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 | KRISHNA GUNDABOLU, MDAssistant Professor of Medicine University of Nebraska | ||
 | HARSH SHAH, DOAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
| RYAN LYNCH, MDAssistant Professor of Medicine University of Washington Medical-Oncologist Seattle Cancer Care Alliance |
 |
DEBORAH STEPHENS, DOAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |  | CATHERINE LEE, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 | TIBOR KOVACSOVICS, MDProfessor of Medicine Huntsman Cancer Institute, University of Utah |  | DOUGLAS SBOROV, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 |
SHAJI KUMAR, MDProfessor of Medicine Mayo Clinic | Photo coming soon! | CHAROLETTE WAGNER, PHARMDHuntsman Cancer Institute, University of Utah |
 | LAURA BICKEL, APRNAdvanced Practice Clinician Huntsman Cancer Institute, University of Utah |  | MARY STEINBACH, APRNAdvanced Practice Clinician Huntsman Cancer Institute, University of Utah |
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this enduring activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Important Information about Claiming CME for this activity:
If you participated in the live meeting titled - 2021 Updates in Hematologic Malignancies on 10/02/2021 in Salt Lake City and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that conference on 10/02/2021. However, you can still enroll in this activity and review the contents as needed.
Available Credit
- 5.00 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 5.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 5.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.
Price
REGISTRATION FEES:
This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0.
Healthcare providers ($0.00)
Industry employees ($200 + 3% Credit card fee)
If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!
If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.
If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.
Cancellation Policy
You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.
Refund Policy
This activity is free for all healthcare providers who are not employees of an ineligible entity.
No refunds will be issued if you have started watching the recorded content.